ColoPrint identifies a patient’s risk of distant, local or regional relapse and stratifies approximately 2/3 of patients as low risk and 1/3 of patients as high risk. The combination of ColoPrint with the patient’s clinical and pathological factors further personalizes the estimate of a patient’s risk of relapse. The information is intended to inform physicians about appropriate treatment options.

 

Low Risk Result:

ColoPrint_Report_LOW_6_1_US1
ColoPrint Low Risk Sample Report

 

A Low Risk result means that a patient with stage II colon cancer has an 8% risk of relapse within 3 years,
and a 11% risk of relapse within 5 years without adjuvant systemic therapy.22

 

High Risk Result:

ColoPrint_Report_HI_6_1_US11
ColoPrint High Risk Sample Report

 

A High Risk result means that a patient with stage II colon cancer has an 20% risk of relapse within 3 years,
and a 22% risk of relapse within 5 years without adjuvant systemic therapy.22